Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 3, 1997, Pages 813-818

  O'Donnell, James M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Beta adrenergic receptor; Betaxolol; CGP 12177; Clenbuterol; Drug discrimination; ICI 118,551; Propranolol

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CHEMISTRY, PHYSICAL; CHOLINERGIC ANTAGONISTS; CLENBUTEROL; DISCRIMINATION (PSYCHOLOGY); MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0030770332     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00038-5     Document Type: Article

References (27)

1. Borsini F., Bendotti C., Thurlby P., Samanin R. Evidence that systemically administered salbutamol reduces food intake in rats by acting on central beta adrenergic sites. Life Sci. 30:1982;905-911.
2. Conway P. G., Tejani-Butt S., Brunswick D. J. Interaction of beta adrenergic agonists and antagonists with beta adrenergic receptors in vivo. J. Pharmacol. Exp. Ther. 241:1987;755-762.
3. Draper N. R., Smith H. Applied regression analysis. 1966;Wiley, New York.
4. Geyer M. A., Frampton S. F. Peripheral mediation of effects of clenbuterol on locomotor and investigatory behavior in rats. Pharmacol. Biochem. Behav. 30:1988;417-420.
5. Granneman J. G., Lahners K. N., Chaudhry A. Molecular cloning and expression of the rat beta-3 adrenergic receptor. Mol. Pharmacol. 40:1991;895-899.
6. Liggett S. B. Functional properties of the rat and human beta-3 adrenergic receptors. Differential agonist activation of recombinant receptors in Chinese hamster ovarian cells Mol. Pharmacol. 42:1992;634-637.
7. Matsumoto K., Ojima K., Ohta H., Watanabe H Beta-2 but not beta 1-adrenoceptors are involved in desipramine enhancement of aggressive behavior in long-term isolated mice. Pharmacol. Biochem. Behav. 49:1994;13-18.
8. McElroy J. F., O'Donnell J. M. Discriminative stimulus properties of clenbuterol. Evidence for beta adrenergic involvement J. Pharmacol. Exp. Ther. 245:1988;155-163.
9. Minneman K. P., Hegstrand L. R., Molinoff P. B. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol. Pharmacol. 16:1979;21-33.
10. Murugaiah K. D., O'Donnell J. M. Effect of clenbuterol on norepinephrine release from rat brain slices in vitro. Res. Commun. Mol. Pathol. Pharmacol. 86:1994;311-324.
11. 3H-norepinephrine release from rat brain slices by beta adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 351:1995;483-490.
12. Murugaiah K. D., O'Donnell J. M. Presynaptic beta-2 adrenergic receptors regulate the release of norepinephrine from cerebral cortical slices. Life Sci. 57:1995;327-332.
13. O'Donnell J. M. Effects of clenbuterol and prenalterol on performance during differential reinforcement of low response rate. J. Pharmacol. Exp. Ther. 241:1987;68-75.
14. O'Donnell J. M. Effects of clenbuterol and prenalterol on behavior maintained under a multiple fixed-interval, fixed-ratio schedule. J. Pharmacol. Exp. Ther. 242:1987;558-594.
15. O'Donnell J. M. Behavioral consequences of activation of beta adrenergic receptors by clenbuterol. Evidence for mediation by the central nervous system Brain Res. Bull. 21:1988;491-497.
16. O'Donnell J. M. Behavioral effects of beta adrenergic agonists and antidepressants after downregulation of beta-2 adrenergic receptors. J. Pharmacol. Exp. Ther. 254:1990;147-157.
17. O'Donnell J. M. Differential sensitivity to the effects of albuterol on operant behavior and locomotor activity. Psychopharmacology (Berlin). 113:1993;243-249.
18. O'Donnell J. M. Effects of clenbuterol and other beta adrenergic agonists on locomotor activity. Res. Commun. Chem. Pathol. Pharmacol. 82:1993;375-379.
19. O'Donnell J. M., Frith S., Wilkins J. Involvement of beta-1 and beta-2 adrenergic receptors in antidepressant-like effects of centrally administered isoproterenol. J. Pharmacol. Exp. Ther. 271:1994;246-254.
20. O'Donnell J. M., Wolfe B. B., Frazer A. Agonist interactions with beta adrenergic receptors in rat brain. J. Pharmacol. Exp. Ther. 228:1984;640-647.
21. Ordway G. A., Gamabarana C., Frazer A. Quantitative autoradiography of central beta adrenoceptor subtypes. Comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol J. Pharmacol. Exp. Ther. 247:1988;379-389.
22. 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. J. Pharmacol. Exp. Ther. 257:1991;681-690.
23. 2-adrenergic receptors in the rat. J. Pharmacol. Exp. Ther. 241:1987;187-195.
24. Rainbow T. C., Parsons B., Wolfe B. B. Quantitative autoradiography of beta-1 and beta-2 adrenergic receptors in rat brain. Proc. Natl. Acad. Sci. USA. 81:1984;1585-1589.
25. Snapper A. G., Kadden R. M., Inglis G. B. State notation of behavioral procedures. Behav. Res. Methods Instrum. 14:1982;329-343.
26. Staehelin M., Simons P., Jaeggi K., Wigger N. CGP-12177. A hydrophilic beta adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells J. Biol. Chem. 258:1983;3496-3502.
27. Vos P., Davenport P. A., Artymyshyn R. P., Frazer A., Wolfe B. B. Selective regulation of beta-2 adrenergic receptors by the chronic administration of the lipophilic beta-adrenergic agonist clenbuterol. An autoradiographic study J. Pharmacol. Exp. Ther. 242:1987;707-712.